{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-23-000131","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.904696+00:00","generated_at":"2026-06-13T02:07:23.927478+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Quest Diagnostics Q2 revenue $2.34B down 4.7% YoY; base business up 9.5%; raises FY revenue guidance","bullets":["Q2 reported EPS $2.05 (+4.6% YoY); adjusted EPS $2.30 (-2.5% YoY).","Base business revenue $2.30B (+9.5% YoY); COVID testing revenue $41M (-88.3%).","FY 2023 revenue guidance raised to $9.12B-$9.22B (from $8.93B-$9.08B).","Adjusted EPS guidance $8.50-$8.90; cash from operations at least $1.3B.","CEO cites strong base business demand but persistent labor turnover pressures."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-23-000131","json":"https://secwatch.observer/filing/0001022079-23-000131.json","markdown":"https://secwatch.observer/filing/0001022079-23-000131.md","text":"https://secwatch.observer/filing/0001022079-23-000131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000131/0001022079-23-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000131/dgx-20230726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:07:23.927478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bfee61b8632efe8564226e8d422678307099d879","claim":"QUEST DIAGNOSTICS INC reported the quarter ended June 30, 2023 results: revenue $2,338, net income $235, EPS $2.05. Guidance raised.","evidence_excerpt":"tight labor market.\" Three Months Ended June 30, Six Months Ended June 30, 2023 2022 Change 2023 2022 Change (dollars in millions, except per share data) Reported: Net revenues $ 2,338 $ 2,453 (4.7) % $ 4,669 $ 5,064 (7.8) % Base business revenues (a) $ 2,297 $ 2,098 9.5 % $ 4,509 $ 4,110 9.7 % COVID-19 testing revenues $ 41 $ 355 (88.3) % $ 160 $ 954 (83.2) %","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000131/0001022079-23-000131-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$2,338"},{"label":"Net income","value":"$235"},{"label":"EPS","value":"$2.05"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ca501c74554be2c20f9c18a18b3e60087512553a","claim":"QUEST DIAGNOSTICS INC reported Full Year 2023 results: revenue $9.12 billion to $9.22 billion, EPS $7.52 to $7.92. Guidance raised.","evidence_excerpt":"Updated Guidance for Full Year 2023 The company updates its Full Year 2023 guidance as follows: Updated Guidance Prior Guidance Low High Low High Net revenues $9.12 billion $9.22 billion $8.93 billion $9.08 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207923000131/0001022079-23-000131-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full Year 2023"},{"label":"Revenue","value":"$9.12 billion to $9.22 billion"},{"label":"EPS","value":"$7.52 to $7.92"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}